- Home
- PLRX vs MFIN Comparison
PLRX vs MFIN Comparison
Compare PLRX & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- MFIN
- Stock Information
- Founded
- PLRX 2015
- MFIN 1995
- Country
- PLRX United States
- MFIN United States
- Employees
- PLRX N/A
- MFIN N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- MFIN Finance: Consumer Services
- Sector
- PLRX Health Care
- MFIN Finance
- Exchange
- PLRX Nasdaq
- MFIN Nasdaq
- Market Cap
- PLRX 165.5M
- MFIN 197.0M
- IPO Year
- PLRX 2020
- MFIN 1996
- Fundamental
- Price
- PLRX $3.08
- MFIN $8.00
- Analyst Decision
- PLRX Buy
- MFIN
- Analyst Count
- PLRX 10
- MFIN 0
- Target Price
- PLRX $14.86
- MFIN N/A
- AVG Volume (30 Days)
- PLRX 3.4M
- MFIN 40.2K
- Earning Date
- PLRX 02-26-2025
- MFIN 02-25-2025
- Dividend Yield
- PLRX N/A
- MFIN 5.41%
- EPS Growth
- PLRX N/A
- MFIN N/A
- EPS
- PLRX N/A
- MFIN 1.69
- Revenue
- PLRX N/A
- MFIN $293,257,000.00
- Revenue This Year
- PLRX N/A
- MFIN N/A
- Revenue Next Year
- PLRX N/A
- MFIN $11.69
- P/E Ratio
- PLRX N/A
- MFIN $4.81
- Revenue Growth
- PLRX N/A
- MFIN 18.48
- 52 Week Low
- PLRX $2.43
- MFIN $6.48
- 52 Week High
- PLRX $18.00
- MFIN $10.50
- Technical
- Relative Strength Index (RSI)
- PLRX 22.51
- MFIN 29.01
- Support Level
- PLRX $2.92
- MFIN $8.18
- Resistance Level
- PLRX $3.16
- MFIN $8.73
- Average True Range (ATR)
- PLRX 0.85
- MFIN 0.27
- MACD
- PLRX -0.39
- MFIN -0.06
- Stochastic Oscillator
- PLRX 6.22
- MFIN 8.33
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.